DAPAGLIFLOZIN

Clinical Indication

Type 1 diabetes

Comments

New patients

Date of classification

December 2021

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety